Seagen
SGEN
#582
Rank
HK$338.39 B
Marketcap
HK$1,794
Share price
-0.07%
Change (1 day)
68.75%
Change (1 year)

EPS for Seagen (SGEN)

EPS in 2023 (TTM): -HK$31.41

According to Seagen 's latest financial reports the company's current EPS (TTM) is -HK$31.44. In 2022 the company made an earnings per share (EPS) of -HK$25.88 an increase over its 2021 EPS that were of -HK$29.01.

EPS history for Seagen from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$31.4121.39%
2022-HK$25.88-10.81%
2021-HK$29.01-206.32%
2020HK$27.29-458.76%
2019-HK$7.61-31.69%
2018-HK$11.1363.22%
2017-HK$6.82-13%
2016-HK$7.846.38%
2015-HK$7.3751.61%
2014-HK$4.8619.23%
2013-HK$4.0810.64%
2012-HK$3.69-64.66%
2011-HK$10.43101.52%
2010-HK$5.18-27.47%
2009-HK$7.14-15.74%
2008-HK$8.4736.71%
2007-HK$6.195.33%
2006-HK$5.885.63%
2005-HK$5.57-59.89%
2004-HK$13.88139.19%
2003-HK$5.80-3.9%
2002-HK$6.04-24.51%
2001-HK$8.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$10.27-132.67%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$16.12-151.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$73.32-333.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$27.92-188.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$30.47-196.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-HK$2.82-91.02%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-HK$2.43-92.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$30.50-2.99%๐Ÿ‡บ๐Ÿ‡ธ USA